FETAL BRADYARRYTHMIA IN OBSTETRIC PRACTICE: DIAGNOSIS, POSSIBILITIES FOR THERAPEUTIC APPROACHES, AND PREVENTION


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Until recently, fetal arrhythmias have been a cause of stillbirths and neonatal and infant deaths in many cases, which has given rise to a new interdisciplinary direction in perinatology - fetal cardiology-arrhythmology. Unlike fetal tachyarrhythmias that are actively treatable, even timely therapy for bradycardia does not always provide a favorable outcome. In this connection, to predict and prevent fetal atrioventricular block are still the subject of active study. The review includes scientific publications (mainly systematic reviews and meta-analyses) by foreign and Russian authors over the past 10 years, which have been found in the Pubmed database and other available search systems: Cochrane, Web of Science, MEDLINE, and Google Scholar. The paper presents the modern ideas about the incidence and pathogenesis of fetal bradyarrhythmias and considers various therapeutic and preventive approaches. Conclusion. Further clinical and laboratory studies are needed to develop a comprehensive examination of and optimal management tactics for pregnant women with different types of fetal bradyarrhythmias

Full Text

Restricted Access

About the authors

Alyona A. POTAPOVA

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: doc.potapovaaa@yandex.ru
Potapova, graduate student of high risk pregnancy department Moscow, Russia

Irina V. TIMOSHINA

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: timoshinairina@yandex.ru
Ph.D., Researcher of high risk pregnancy department Moscow, Russia

Zulfiya S. KHODZHAEVA

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: zkhodjaeva@mail.ru
M.D., Professor, Deputy Director of obstetrics institute Moscow, Russia

Ekaterina L. BOCKERIA

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: e_bokeriya@oparina4.ru
M.D., Professor, Head of the department of pathology of newborn and premature babies Moscow, Russia

References

  1. Бокерия Е.Л. Перинатальная кардиология: настоящее и будущее. Часть II: нарушение ритма сердца и проводимости. Российский вестник перинатологии и педиатрии. 2019; 64(4): 6-10
  2. Brito-Zerön P., Izmirly P.M., Ramos-Casals M., Buyon J.P., Khamashta M.A. The clinical spectrum of autoimmune congenital heart block. Nat. Rev. Rheumatol. 2015; 11(5): 301-12. https://dx.doi.org/10.1038/nrrheum.2015.29.
  3. Gleicher N., Elkayam U. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials. Autoimmun. Rev. 2013; 12(11): 1039-45. https://dx.doi.org/10.1016/j.autrev.2013.04.006.
  4. Wang B., Hu S., Shi D., Bing Z., Li Z. Arrhythmia and/or cardiomyopathy related to maternal autoantibodies: descriptive analysis of a series of 16 cases from a single center. Front. Pediatr. 2019; 7: 465. https://dx.doi.org/10.3389/ fped.2019.00465.
  5. Ho A., Gordon P., Rosenthal E., Simpson J., Miller O., Sharland G. Isolated complete heart block in the fetus. Am. J. Cardiol. 2015; 116(1): 142-7. https:// dx.doi.org/10.1016/j.amjcard.2015.03.051.
  6. Hunter L.E., Simpson J.M. Atrioventricular block during fetal life. J. Saudi Heart Assoc. 2015; 27(3): 164-78. https://dx.doi.org/10.1016/josha.2014.07.001.
  7. Кошелева Н.М., Алекберова З.С. Неонатальная волчанка. Современная ревматология. 2015; 9(4): 92-7. [Kosheleva N.M., Alekberova Z.S. Neonatal lupus. Modern Rheumatology Journal. 2015; 9(4): 92-7. (in Russian)]. https:// dx.doi.org/10.14412/1996-7012-2015-4-92-97.
  8. Buyon J.P., Hiebert R., Copel J., Craft J., Friedman D., Katholi M. et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J. Am. Coll. Cardiol. 1998; 31(7): 1658-66. https://dx.doi.org/10.1016/S0735-1097(98)00161-2.
  9. Ambrosi A., Wahren-Herlenius M. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies. Arthritis Res. Ther. 2012; 14(2): 208. https://dx.doi.org/10.1186/ar3787.
  10. Baruteau A.E., Pass R.H., Thambo J.B., Behaghel A., Le Pennec S., Perdreau E. et al. Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management. Eur. J. Pediatr. 2016; 175(9): 1235-48. https:// dx.doi.org/10.1007/s00431-016-2748-0.
  11. Сафонова И.Н. Фетальные аритмии: антенатальная ультразвуковая дифференциальная диагностика, прогнозирование постнатальных результатов и перинатальная практика. SonoAce Ultrasound. 2014; 26: 17-29.
  12. Mivelaz Y., Raboisson M.J., Abadir S., Sarquella-Brugada G., Fournier A., Fouron J.C. Ultrasonographic diagnosis of delayed atrioventricular conduction during fetal life: a reliability study. Am. J. Obstet. Gynecol. 2010; 203(2): 174. e1-7. https://dx.doi.org/10.1016/j.ajog.2010.02.024.
  13. Беспалова Е.Д., Суратова О.Г., Бокерия Е.Л., Бартагова М.Н., Гасанова Р.М., Тюменева А.И. Диагностика и лечение кардиальной патологии у плода. Бокерия Л.А., ред. М.: Издательство НЦССХ им. А.Н. Бакулева; 2015. 244 с.
  14. Izmirly P.M., Costedoat-Chalumeau N., Pisoni C.N., Khamashta M.A., Kim M.Y., Saxena A. et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation. 2012; 126(1): 76-82. https://dx.doi.org/10.1161/ CIRCULATIONAHA.111.089268.
  15. Saxena A., Izmirly P.M., Mendez B., Buyon J.P., Friedman D.M. Prevention and treatment in utero of autoimmune-associated congenital heart block. Cardiol. Rev. 2014; 22(6): 263-7. https://dx.doi.org/10.1097/CRD.0000000000000026.
  16. Clowse M.E.B., Eudy A.M., Kiernan E., Williams M.R., Bermas B., Chakravarty E. et al. The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices. Rheumatology (Oxford). 2018; 57(Suppl. 5): v9-17. https://dx.doi.org/10.1093/rheumatology/key141.
  17. Zhou K.Y., Hua Y.M. Autoimmune-associated congenital heart block: a new insight in fetal life. Chin. Med. J. (Engl). 2017; 130(23): 2863-71. https://dx.doi. org/10.4103/0366-6999.219160.
  18. Martinez-Sdnchez N., Pérez-Pinto S., Robles-Marhuenda Â., Arnalich-Ferndndez F., Martin Camedn M., Hueso Zalvide E. et al. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study. Immunol. Res. 2017; 65(2): 487-94. https://dx.doi.org/10.1007/s12026-016-8888-5.
  19. Eliasson H., Sonesson S.E., Sharland G., Granath F., Simpson J.M., Carvalho J.S. et al. Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients. Circulation. 2011; 124(18): 1919-26. https:// dx.doi.org/10.1161/CIRCULATIONAHA.111.041970.
  20. Cuneo B.F., Zhao H., Strasburger J.F., Ovadia M., Huhta J.C., Wakai R.T. Atrial and ventricular rate response and patterns of heart rate acceleration during maternal-fetal terbutaline treatment of fetal complete heart block. Am. J. Cardiol. 2007; 100(4): 661-5. https://dx.doi.org/10.1016/j.amjcard.2007.03.081.
  21. Nimmerjahn F., Ravetch J.V. The antiinflammatory activity of IgG: the intravenous IgG paradox. J. Exp. Med. 2007; 204(1): 11-5. https://dx.doi. org/10.1084/jem.20061788.
  22. Trucco S.M., Jaeggi E., Cuneo B., Moon-Grady A.J., Silverman E., Silverman N. et al. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J. Am. Coll. Cardiol. 2011; 57(6): 715-23. https://dx.doi.org/10.1016/j.jacc.2010.09.044.
  23. Tunks R.D., Clowse M.E., Miller S.G., Brancazio L.R., Barker P.C. Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents. Am. J. Obstet. Gynecol. 2013; 208(1): 64.e1-7. https:// dx.doi.org/10.1016/j.ajog.2012.09.020.
  24. Izmirly P.M., Buyon J.P., Saxena A. Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease. Curr. Opin. Rheumatol. 2012; 24(5): 466-72. https://dx.doi.org/10.1097/ BOR.0b013e328356226b.
  25. Lopes L.M., Tavares G.M., Damiano A.P., Lopes M.A., Aiello V.D., Schultz R. et al. Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution. Circulation. 2008; 118(12): 1268-75. https://dx.doi. org/ 10.1161/CIRCULATIONAHA.107.735118.
  26. Mitchell J.L., Cuneo B.F, Etheridge S.P., Horigome H., Weng H.Y., Benson D.W. Fetal heart rate predictors of long QT syndrome. Circulation. 2012; 126(23): 2688-95. https://dx.doi.org/10.1161/CIRCULATIONAHA.112.114132.
  27. Skog A., Wahren-Herlenius M., Sundström B., Bremme K., Sonesson S.E. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies. Pediatrics. 2008; 121(4): e803-9. https://dx.doi.org/10.1542/peds.2007-1659.
  28. Fredi M., Andreoli L., Bacco B., Bertero T., Bortoluzzi A., Breda S. et al. First report of the Italian Registry on immune-mediated congenital heart block (Lu. Ne Registry). Front. Cardiovasc. Med. 2019; 6: 11. https://dx.doi.org/10.3389/ fcvm.2019.00011.
  29. Callan N.A., Maggio M., Steger S., Kan J.S. Fetal echocardiography: indications for referral, prenatal diagnoses, and outcomes. Am. J. Perinatol. 1991; 8(6): 390-4. https://dx.doi.org/10.1055/s-2007-999423.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies